Brief: Royalty Pharma To Purchase Up To $1.5 Bln of PTC Therapeutics’ Royalty on Evrysdi

Royalty Pharma

19/10/2023 14:09

Oct 19 (Reuters) - Royalty Pharma PLC  RPRX.O :
    * ROYALTY PHARMA ANNOUNCES AGREEMENT TO PURCHASE UP TO $1.5
BILLION OF PTC THERAPEUTICS’ ROYALTY ON EVRYSDI
    * ROYALTY PHARMA : PTC THERAPEUTICS HAS OPTION TO SELL REST
OF
ROYALTY FOR UP TO $500 MILLION
    * ROYALTY PHARMA : HAS OPTION TO BUY HALF OF REST OF ROYALTY
FOR
UP TO $250 MILLION
    * ROYALTY PHARMA : TRANSACTION EXPECTED TO ENHANCE LONG-TERM
ADJUSTED CASH RECEIPTS GROWTH (NON-GAAP)

Source text for Eikon:  ID:nGNX65kk0l 
Further company coverage:  RPRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))